Goals for Adherence with Low-cost Incentives (GOALS): a protocol for a randomized controlled trial evaluating the impact of small airtime incentives on ART adherence among young people living with HIV in Kampala, Uganda

被引:0
|
作者
Linnemayr, Sebastian [1 ]
Huang, Haijing Crystal [2 ]
Wagner, Zachary [1 ]
Onkundi, Faith Kemunto [2 ]
Mukasa, Barbara [3 ]
Odiit, Mary [3 ]
机构
[1] RAND Corp, Santa Monica, CA USA
[2] IDinsight, San Francisco, CA 94105 USA
[3] Mildmay Uganda, Kampala, Uganda
关键词
HIV; AIDS; Behavioral Economics; Incentives; Goals; Uganda; Global Health; Randomized controlled trial; ECONOMIC INCENTIVES; SELF-EFFICACY;
D O I
10.1186/s13063-023-07449-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundTreatment outcomes of HIV-positive individuals are threatened by low antiretroviral therapy (ART) adherence, a problem that is particularly acute among youth. Incentives are a promising tool to support ART adherence, but traditional incentive designs rewarding uniformly high levels of the desired health behavior may demotivate those with low levels of the behavior. In this study, we investigate the effectiveness of alternative approaches to target-setting for incentive eligibility using subgoals (i.e., individual-specific, interim targets leading up to the optimal target).Methods / designWe will enroll 628 HIV-positive youth between ages 15 and 30 into a 3-year randomized controlled trial. Participants will be randomized 1:1:1:1 to a control arm or one of three intervention arms (n = 157 each) that allow them to enter a prize drawing for small incentives if their ART adherence meets the given goal. In the first arm (T1, assigned subgoal), goals will be externally assigned and adapted to their initial adherence level. In the second arm (T2, participatory subgoal), participants can set their own interim goals. In the third arm (T3, fixed goal), all participants must reach the same target goal of 90% adherence. T1 and T2 participants are required to reach 90% adherence by month 12 to participate in a larger prize drawing. The control group receives the usual standard of care. All four groups will receive weekly motivational messages; the three treatment groups will additionally receive reminders of their upcoming prize drawing. Adherence will be measured continuously throughout the intervention period using electronic devices and for 12 months post-intervention. Surveys will be conducted at baseline and every 6 months. Viral loads will be measured annually. The primary outcome is Wisepill-measured adherence and a binary measure for whether the person took at least 90% of their pills. The secondary outcome is the log-transformed viral load as a continuous measure.DiscussionOur study is one of the first to apply insights about the psychology and behavioral economics of goal-setting to the design of incentives, by testing whether conditioning the eligibility threshold for incentives on subgoals (interim goals leading up to the ultimate, high goal) improves motivation and adherence more than setting a uniformly highly goal, and a comparison group.
引用
收藏
页数:14
相关论文
共 20 条
  • [1] Goals for Adherence with Low-cost Incentives (GOALS): a protocol for a randomized controlled trial evaluating the impact of small airtime incentives on ART adherence among young people living with HIV in Kampala, Uganda
    Sebastian Linnemayr
    Haijing Crystal Huang
    Zachary Wagner
    Faith Kemunto Onkundi
    Barbara Mukasa
    Mary Odiit
    Trials, 24
  • [2] Behavioral Economics Incentives to Support HIV Treatment Adherence (BEST): Protocol for a randomized controlled trial in Uganda
    Linnemayr, Sebastian
    Stecher, Chad
    Saya, Uzaib
    MacCarthy, Sarah
    Wagner, Zachary
    Jennings, Larissa
    Mukasa, Barbara
    TRIALS, 2020, 21 (01)
  • [3] Behavioral Economics Incentives to Support HIV Treatment Adherence (BEST): Protocol for a randomized controlled trial in Uganda
    Sebastian Linnemayr
    Chad Stecher
    Uzaib Saya
    Sarah MacCarthy
    Zachary Wagner
    Larissa Jennings
    Barbara Mukasa
    Trials, 21
  • [4] INcentives and ReMINDers to Improve Long-Term Medication Adherence (INMIND): impact of a pilot randomized controlled trial in a large HIV clinic in Uganda
    Linnemayr, Sebastian
    Odiit, Mary
    Mukasa, Barbara
    Ghai, Ishita
    Stecher, Chad
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 (06)
  • [5] An mHealth Intervention to Address Depression and Improve Antiretroviral Therapy Adherence Among Youths Living With HIV in Uganda: Protocol for a Pilot Randomized Controlled Trial
    Nabunya, Proscovia
    Cavazos-Rehg, Patricia
    Mugisha, James
    Kasson, Erin
    Namuyaba, Olive Imelda
    Najjuuko, Claire
    Nsubuga, Edward
    Filiatreau, Lindsey M.
    Mwebembezi, Abel
    Ssewamala, Fred M.
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [6] Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial
    Joska, John A.
    Andersen, Lena S.
    Smith-Alvarez, Rosana
    Magidson, Jessica
    Lee, Jasper S.
    O'Cleirigh, Conall
    Safren, Steven A.
    JMIR RESEARCH PROTOCOLS, 2020, 9 (02):
  • [7] The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial
    Mogoba, Phepo
    Lesosky, Maia
    Zerbe, Allison
    Falcao, Joana
    Mellins, Claude Ann
    Desmond, Christopher
    Arnaldo, Carlos
    Kapogiannis, Bill
    Myer, Landon
    Abrams, Elaine J.
    TRIALS, 2021, 22 (01)
  • [8] The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial
    Phepo Mogoba
    Maia Lesosky
    Allison Zerbe
    Joana Falcao
    Claude Ann Mellins
    Christopher Desmond
    Carlos Arnaldo
    Bill Kapogiannis
    Landon Myer
    Elaine J. Abrams
    Trials, 22
  • [9] Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial
    Chamie, Gabriel
    Hahn, Judith A.
    Kekibiina, Allen
    Emenyonu, Nneka, I
    Beesiga, Brian
    Marson, Kara
    Fatch, Robin
    Lodi, Sara
    Adong, Julian
    Thirumurthy, Harsha
    McDonell, Michael G.
    Gandhi, Monica
    Bryant, Kendall
    Havlir, Diane, V
    Kamya, Moses R.
    Muyindike, Winnie R.
    LANCET GLOBAL HEALTH, 2023, 11 (12): : E1899 - E1910
  • [10] Correction to: The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial
    Phepo Mogoba
    Maia Lesosky
    Allison Zerbe
    Joana Falcao
    Claude Ann Mellins
    Christopher Desmond
    Carlos Arnaldo
    Bill Kapogiannis
    Landon Myer
    Elaine J. Abrams
    Trials, 23